PEBP1 (phosphatidylethanolamine binding protein 1)
2007-11-01 Sandy Beach  , Kam C Yeung   AffiliationDepartment of Cancer Biology, Biochemistry, College of Medicine, University of Toledo, Health Science Campus-(formerly Medical University of Ohio), 3035 Arlington Ave., Toledo, OH 43614, USA
Identity
HGNC
LOCATION
12q24.23
LOCUSID
ALIAS
HCNP,HCNPpp,HEL-210,HEL-S-34,HEL-S-96,PBP,PEBP,PEBP-1,RKIP
FUSION GENES
DNA/RNA

Diagram of the RKIP gene. Exons are depicted as filled boxes and untranslated regions are unfilled boxes. Introns are represented as lines between exons. Intron, exon, and untranslated region sizes are described in base pairs.
Description
The gene is composed of 4 exons spanning a region of 9,520 base pairs.
Transcription
The mRNA contains 1507 nucleotides. Alternative splicing has not been described. In prostate cancer cell lines RKIP transcription is repressed by Snail through an E-box in its promoter. Promoter methylation does not seem to cause loss of RKIP expression.
Pseudogene
RKIP has two putative pseudogenes located on chromosomes 2 and 14. These are intronless sequences with no verified expression to date.
Proteins
Note
RKIP belongs to a highly conserved family of phospholipid-binding proteins, which have been recognized and studied for several years as PEBP. These proteins are represented in eukaryotes, bacteria, and archae. One of the interesting properties of some PEBP family members is that they are cleaved at the N-terminus to release an undecapeptide which has been named hippocampal cholinergic neurostimulating peptide (HCNP).

Stereo view of the human RKIP structure prepared with Pymol (Delano, 2002). Pocket residues H86 (left), H118 (right), D70 (top) and Y120 (bottom) are indicated.
Description
RKIP is an 187 amino acid protein with a molecular mass of 21-23 kDa. The crystal structures of human, bovine and plant PEBPs are solved revealing no homologies to domains of known functions. The structure of RKIP features a b-fold formed by two anti-parallel b-sheets, a small C-terminal aba element, and a cavity at the surface, which could accommodate a small anion such as a phosphoryl group (see diagram above). Amino acids forming this cavity are conserved among all PEBP family members and constitute the PEB motif.
Expression
RKIP and its mammalian homologs are widely expressed in tissues; it has been detected in lung, oviduct and ovary, mammary glands, uterus, prostate epithelium, thyroid, mesenteric lymph node, megakaryocytes of the heart; spleen, liver, and epididymis, testis, spermatids, Leydig cells, steroidogenic cells of the adrenal gland zona fasiculata, small intestine, plasma cells, and neural cells such as brain oliodendricytes, Schwann cells, and Pukinje cells.
Localisation
RKIP is localized in the cytoplasm and at the plasma membrane.
Function
RKIP inhibits the Raf/MEK/ERK cascade. Identified as a Raf-1 interacting protein in a yeast two-hybrid screen, RKIP was found to inhibit phosphorylation and activation of MEK by Raf-1. RKIP inhibits the phosphorylation of the N-region of Raf-1 by (21-activated kinase) Pak and Src family kinases thereby inhibiting activation of Raf-1. PKC phosphorylation of RKIP following GPCR stimulation causes its release from Raf-1. Classical and atypical PKCs can phosphorylate RKIP at serine 153 causing dissociation of the Raf-1 kinase domain and RKIP, indicating that PKC can mediate ERK activation through RKIP. Once free from Raf-1, RKIP was shown to bind GRK-2 and block its activity, promoting and enhancing G protein signaling and MEK/ERK signaling.
RKIP appears to support macrophage differentiation via inhibition of the NFKB pathway. RKIP inhibits the NF-kappaB pathway through interaction with NIK, TAK1, and IKK. RKIP was a novel effector of apoptosis signaling; this may occur by modulation of the NF-kappaB pathway and/or the regulation of the spindle checkpoint via Aurora B kinase and the spindle checkpoint by RKIP. RKIP regulation of Aurora kinase B and the spindle checkpoint through Raf-1/MEK/ERK signaling influences cell cycle fidelity.
RKIP has serine protease activity. Purified RKIP was found to inhibit the serine proteases thrombin, chymotrypsin, and neuropsin.
HCNP, the N-terminal fragment of RKIP, may play a role in phospholipid organization of the myelin sheath and septal cholinergic development of the hippocampus. HCNP can act on frog cardiac mechanical performance, exerting a negative inotropism. Results of these experiments suggest that RKIP/HCNP may be a new endocrine factor that regulates cardiac physiology. RKIP downregulation may be associated with the congenital heart disease manifested in Down syndrome. RKIP downregulation was found in the rat right ventricle and in the interventricular septum upon cardiac remodeling.
RKIP has been found in the male reproductive tract with implications in the organization of sperm membranes during spermiogenesis. It has been identified as a decapacitation factor in mouse spermatozoa. RKIP and other proteins inhibited progesterone-induced acrosome reaction and zona pellucida binding of sperm.
RKIP appears to support macrophage differentiation via inhibition of the NFKB pathway. RKIP inhibits the NF-kappaB pathway through interaction with NIK, TAK1, and IKK. RKIP was a novel effector of apoptosis signaling; this may occur by modulation of the NF-kappaB pathway and/or the regulation of the spindle checkpoint via Aurora B kinase and the spindle checkpoint by RKIP. RKIP regulation of Aurora kinase B and the spindle checkpoint through Raf-1/MEK/ERK signaling influences cell cycle fidelity.
RKIP has serine protease activity. Purified RKIP was found to inhibit the serine proteases thrombin, chymotrypsin, and neuropsin.
HCNP, the N-terminal fragment of RKIP, may play a role in phospholipid organization of the myelin sheath and septal cholinergic development of the hippocampus. HCNP can act on frog cardiac mechanical performance, exerting a negative inotropism. Results of these experiments suggest that RKIP/HCNP may be a new endocrine factor that regulates cardiac physiology. RKIP downregulation may be associated with the congenital heart disease manifested in Down syndrome. RKIP downregulation was found in the rat right ventricle and in the interventricular septum upon cardiac remodeling.
RKIP has been found in the male reproductive tract with implications in the organization of sperm membranes during spermiogenesis. It has been identified as a decapacitation factor in mouse spermatozoa. RKIP and other proteins inhibited progesterone-induced acrosome reaction and zona pellucida binding of sperm.
Homology
No significant sequence homology to other proteins. Humans have two known family members, RKIP and PEBP4. RKIP has high sequence identity to mouse, rat, bovine, and monkey phosphatidylethanolamine binding proteins.
Implicated in
Entity name
Breast cancer
Oncogenesis
Immunohistochemical examination of breast cancer lymph node metastases showed significant loss of RKIP protein expression compared to normal breast duct epithelia and primary tumors. There was a weak negative correlation between RKIP expression and apoptosis in breast tumors that did not have associated lymph node metastases.
Low levels of RKIP may allow cancer cells to evade apoptosis. Breast cancer cell lines expressing low levels of RKIP undergo apoptosis following ectopic RKIP addition or Taxol treatment, which induced RKIP expression.
Low levels of RKIP may allow cancer cells to evade apoptosis. Breast cancer cell lines expressing low levels of RKIP undergo apoptosis following ectopic RKIP addition or Taxol treatment, which induced RKIP expression.
Entity name
Prostate cancer
Prognosis
Decreased protein expression of RKIP may be a prognostic marker in prostate cancer, with low RKIP levels indicating early PSA failure.
Oncogenesis
Low levels of RKIP may protect cancer cells against apoptosis. Tumorgenic prostate cancer cell lines expressing low levels of RKIP increase their RKIP expression following treatment with a chemotherapeutic drug, sensitizing the cells to apoptosis. Cell lines with higher RKIP expression can be made resistant to apoptosis when RKIP is knocked down.
RKIP is downregulated in prostate cancer progression and metastasis. Modulation of RKIP expression in prostate cancer cell lines changes invasive ability in vitro as well as development of metastases in vivo, with loss of RKIP corresponding to increased invasiveness and metastatic spread. MEK/ERK activation was associated with low or decreased RKIP expression in vitro, and vice-versa.
RKIP mRNA can activate interferon-inducible 2,5-oligoadenylate synthetases (OAS), leading to RNase L activation. RNase L deficiency in prostate cancer cell lines (PC3, Du145, LNCap) is associated with resistance to apoptosis through OAS activation.
RKIP is downregulated in prostate cancer progression and metastasis. Modulation of RKIP expression in prostate cancer cell lines changes invasive ability in vitro as well as development of metastases in vivo, with loss of RKIP corresponding to increased invasiveness and metastatic spread. MEK/ERK activation was associated with low or decreased RKIP expression in vitro, and vice-versa.
RKIP mRNA can activate interferon-inducible 2,5-oligoadenylate synthetases (OAS), leading to RNase L activation. RNase L deficiency in prostate cancer cell lines (PC3, Du145, LNCap) is associated with resistance to apoptosis through OAS activation.
Entity name
Melanoma
Note
RKIP mRNA and protein expression is reduced in melanoma cell lines versus normal melanocytes. AP-1 activation and ERK1/ERK2 phosphorylation decreased in Mel Im cells stably transfected with RKIP compared to control transfected cells. Immunohistochemical analyses showed reduced RKIP in primary melanoma versus normal normal skin, and further reduction in melanoma metastases. RKIP may act by inhibiting B-Raf kinase activity, as demonstrated in melanoma cell lines in vitro.
Entity name
Hepatocellular carcinoma
Note
Hepatocellular carcinoma cell lines and HCC liver tissue showed decreased RKIP expression as compared to primary human hepatocytes or adjacent peritumoral tissues. Low RKIP expression was correlated with increased ERK activation and modulation of RKIP expression antagonized MAPK signaling in vitro.
Entity name
Colorectal cancer
Note
Loss of RKIP, as studied in tissue microarrays of MMR-proficient and deficient colorectal cancer samples, was a marker of tumor progression and metastasis. Diminished RKIP expression was significantly positively associated with worse survival.
Entity name
Insulinoma / Islet neoplasia
Note
Insulinomas showed decreased or absent RKIP expression as compared to normal nearby islets. ß-cell line HIT-TI5 proliferation, but not apoptotis, was inhibited by RKIP.
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 17952120 | 2008 | Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. | Beach S et al |
| 14766752 | 2004 | RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. | Chatterjee D et al |
| 17018026 | 2006 | Identification and characterization of PEBP as a calpain substrate. | Chen Q et al |
| 12551925 | 2003 | Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. | Corbit KC et al |
| 16916643 | 2006 | Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. | Eves EM et al |
| 16175585 | 2006 | Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. | Fu Z et al |
| 12813171 | 2003 | Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. | Fu Z et al |
| 16243812 | 2005 | Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. | Hagan S et al |
| 11034991 | 2001 | The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors. | Hengst U et al |
| 17170028 | 2007 | Cross-regulation of VPAC(2) receptor desensitization by M(3) receptors via PKC-mediated phosphorylation of RKIP and inhibition of GRK2. | Huang J et al |
| 15466208 | 2004 | Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. | Jazirehi AR et al |
| 15565643 | 2005 | The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein. | Keller ET et al |
| 11023813 | 2000 | Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. | Kolch W et al |
| 11514577 | 2001 | Human phosphatidylethanolamine-binding protein facilitates heterotrimeric G protein-dependent signaling. | Kroslak T et al |
| 17030190 | 2006 | Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. | Lee HC et al |
| 14654844 | 2003 | Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. | Lorenz K et al |
| 17439843 | 2007 | Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. | Minoo P et al |
| 17145707 | 2006 | Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells. | Molinaro RJ et al |
| 8738137 | 1996 | Sequence analysis and immunolocalisation of phosphatidylethanolamine binding protein (PBP) in human brain tissue. | Moore C et al |
| 15327891 | 2004 | Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. | Odabaei G et al |
| 17097642 | 2006 | Regulation of RKIP binding to the N-region of the Raf-1 kinase. | Park S et al |
| 15782137 | 2005 | RKIP downregulates B-Raf kinase activity in melanoma cancer cells. | Park S et al |
| 17214889 | 2007 | MAP kinase meets mitosis: a role for Raf Kinase Inhibitory Protein in spindle checkpoint regulation. | Rosner MR et al |
| 15289323 | 2004 | Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. | Schuierer MM et al |
| 7807553 | 1994 | Amino acid sequence of the Homo sapiens brain 21-23-kDa protein (neuropolypeptide h3), comparison with its counterparts from Rattus norvegicus and Bos taurus species, and expression of its mRNA in different tissues. | Seddiqi N et al |
| 12037323 | 2002 | The crystal structure of PEBP-2, a homologue of the PEBP/RKIP family. | Simister PC et al |
| 17292798 | 2007 | Raf kinase inhibitory protein knockout mice: expression in the brain and olfaction deficit. | Theroux S et al |
| 15886202 | 2005 | Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. | Trakul N et al |
| 15155742 | 2004 | Differentiation induction of human keratinocytes by phosphatidylethanolamine-binding protein. | Yamazaki T et al |
| 10757792 | 2000 | Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. | Yeung K et al |
| 10490027 | 1999 | Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. | Yeung K et al |
| 11585904 | 2001 | Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. | Yeung KC et al |
| 15349122 | 2004 | Raf kinase inhibitory protein inhibits beta-cell proliferation. | Zhang L et al |
Other Information
Locus ID:
NCBI: 5037
MIM: 604591
HGNC: 8630
Ensembl: ENSG00000089220
Variants:
dbSNP: 5037
ClinVar: 5037
TCGA: ENSG00000089220
COSMIC: PEBP1
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000089220 | ENST00000261313 | P30086 |
| ENSG00000089220 | ENST00000261313 | D9IAI1 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38135812 | 2024 | Clinical Significance of Frequently Down-Regulated Phosphatidylethanolamine-Binding Protein-1 in Gallbladder Cancer. | 0 |
| 38363884 | 2024 | Prognostic significance of RKIP, TGM2, and CMTM4 expression in oral squamous cell carcinoma. | 0 |
| 38608337 | 2024 | Raf kinase inhibitor protein expression in smooth muscle tumours of the uterus: a diagnostic marker for leiomyosarcoma? | 0 |
| 38914697 | 2024 | Bmi-1 promotes the proliferation, migration and invasion, and inhibits cell apoptosis of human retinoblastoma cells via RKIP. | 0 |
| 38135812 | 2024 | Clinical Significance of Frequently Down-Regulated Phosphatidylethanolamine-Binding Protein-1 in Gallbladder Cancer. | 0 |
| 38363884 | 2024 | Prognostic significance of RKIP, TGM2, and CMTM4 expression in oral squamous cell carcinoma. | 0 |
| 38608337 | 2024 | Raf kinase inhibitor protein expression in smooth muscle tumours of the uterus: a diagnostic marker for leiomyosarcoma? | 0 |
| 38914697 | 2024 | Bmi-1 promotes the proliferation, migration and invasion, and inhibits cell apoptosis of human retinoblastoma cells via RKIP. | 0 |
| 36382638 | 2023 | RKIP suppresses the influenza A virus‑induced airway inflammatory response via the ERK/MAPK pathway. | 0 |
| 36805338 | 2023 | RKIP localizes to the nucleus through a bipartite nuclear localization signal and interaction with importin α to regulate mitotic progression. | 0 |
| 37475847 | 2023 | Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor. | 1 |
| 36382638 | 2023 | RKIP suppresses the influenza A virus‑induced airway inflammatory response via the ERK/MAPK pathway. | 0 |
| 36805338 | 2023 | RKIP localizes to the nucleus through a bipartite nuclear localization signal and interaction with importin α to regulate mitotic progression. | 0 |
| 37475847 | 2023 | Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor. | 1 |
| 34728553 | 2022 | RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in NF2-Deficient Conditions. | 4 |
Citation
Sandy Beach ; Kam C Yeung
PEBP1 (phosphatidylethanolamine binding protein 1)
Atlas Genet Cytogenet Oncol Haematol. 2007-11-01
Online version: http://atlasgeneticsoncology.org/gene/44021/pebp1-(phosphatidylethanolamine-binding-protein-1)
